Free Trial

Immix Biopharma (IMMX) Insider Trading & Ownership

Immix Biopharma logo
$1.60
-0.05 (-3.03%)
(As of 10/31/2024 ET)

Immix Biopharma (NASDAQ:IMMX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
48.90%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$341,415.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get IMMX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Immix Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

IMMX Insider Buying and Selling by Quarter

Immix Biopharma Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/16/2024Carey NgDirectorBuy10,000$1.86$18,600.00  
7/24/2024Jason HsuDirectorBuy6,000$2.15$12,900.00  
7/18/2024Jason HsuDirectorBuy3,200$2.07$6,624.00  
6/7/2024Gabriel S MorrisCFOBuy2,500$2.12$5,300.00  
6/7/2024Ilya M RachmanCEOBuy2,600$2.13$5,538.00  
6/4/2024Gabriel S MorrisCFOBuy3,300$1.81$5,973.00  
5/14/2024Gabriel S MorrisCFOBuy4,500$2.23$10,035.00  
5/14/2024Ilya M RachmanCEOBuy4,300$2.25$9,675.00  
12/11/2023Jason HsuDirectorBuy31,000$4.67$144,770.00  
12/8/2023Jason HsuDirectorBuy25,000$4.88$122,000.00  
(Data available from 1/1/2013 forward)

IMMX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Immix Biopharma includes Carey Ng, Gabriel S Morris, Helen C Adams, Ilya M Rachman, Jason Hsu, Magda Marquet, Melissa Jane Buchan, and Sean Senn. Learn more on insiders at IMMX.

48.90% of Immix Biopharma stock is owned by insiders. Learn more on IMMX's insider holdings.

The following insiders have purchased IMMX shares in the last 24 months: Carey Ng ($44,400.00), Gabriel S Morris ($21,308.00), Helen C Adams ($38,480.00), Ilya M Rachman ($20,413.00), Jason Hsu ($286,294.00), Magda Marquet ($26,710.00), and Melissa Jane Buchan ($49,200.00).

Insiders have purchased a total of 151,600 IMMX shares in the last 24 months for a total of $486,805.00 bought.

Immix Biopharma Key Executives

  • Dr. Ilya Rachman M.B.A. (Age 51)
    M.D., MBA, Ph.D., Co-Founder, CEO & Chairman
    Compensation: $637.5k
  • Mr. Gabriel Morris B.A. (Age 37)
    CFO & Director
    Compensation: $637.5k
  • Mr. Sean Senn J.D.
    M.B.A., M.Sc., MBA, MSc, Co-Founder
  • Dr. Vladimir P. Torchilin D.Sc. (Age 77)
    MSE, Ph.D., Scientific Co-Founder
  • Mr. Ben H. Lyon J.D.
    Executive VP & General Counsel
  • Dr. Graham Ross FFPM (Age 64)
    M.D., Chief Medical Officer & Head of Clinical Development
  • Mr. Nandan Oza B.S. (Age 62)
    Head of Chemistry, Manufacturing & Control
  • Dr. David Marks
    Chief Medical Officer of Cell Therapy
  • Mr. Gerhard Bauer
    Head of Cell Thearpy Manufacturing


This page (NASDAQ:IMMX) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners